갱년기장애 치료 시장 보고서(2026년)

Menopausal disorder treatment refers to medical and therapeutic interventions designed to relieve symptoms associated with menopause, such as hot flashes, mood changes, sleep disturbances, and hormonal imbalances, with the goal of improving the quality of life and well-being of individuals during the menopausal transition.

The primary treatment types for menopausal disorders include hormone replacement therapy, non-hormonal treatments, herbal supplements, and lifestyle modifications. Hormone replacement therapy (HRT) helps restore hormone balance in women experiencing menopause-related symptoms such as hot flashes, mood swings, and bone density loss. These treatments are applicable across different stages, including menopause, postmenopause, and perimenopause, and address symptoms such as hot flashes, night sweats, mood swings, and vaginal dryness. They are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other channels, and are used by hospitals, specialty clinics, homecare settings, and other end users.

Tariffs have impacted the menopausal disorder treatment market by increasing costs of imported hormone formulations, active pharmaceutical ingredients, and specialty supplements. These effects are most evident in hormone replacement therapy and non-hormonal drug segments, particularly across North America, Europe, and Asia-Pacific. Higher tariffs have contributed to increased treatment costs in hospital and retail pharmacy channels. However, tariffs have also encouraged local drug manufacturing and wider adoption of lifestyle-based and non-pharmacological menopause management options.

The menopausal disorder treatment market research report is one of a series of new reports from The Business Research Company that provides menopausal disorder treatment market statistics, including menopausal disorder treatment industry global market size, regional shares, competitors with a menopausal disorder treatment market share, detailed menopausal disorder treatment market segments, market trends and opportunities, and any further data you may need to thrive in the menopausal disorder treatment industry. This menopausal disorder treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The menopausal disorder treatment market size has grown strongly in recent years. It will grow from $11.47 billion in 2025 to $12.32 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to growing aging female population, widespread use of hormone replacement therapy, increased diagnosis of menopausal symptoms, expansion of gynecology care services, rising healthcare access for women.

The menopausal disorder treatment market size is expected to see strong growth in the next few years. It will grow to $16.26 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to growth in demand for safer menopause treatments, increasing focus on individualized therapy plans, rising awareness of long-term hrt risks, expansion of digital women's health platforms, growing adoption of preventive women's healthcare. Major trends in the forecast period include rising preference for non-hormonal menopause therapies, increasing adoption of personalized hormone replacement therapy, growing use of lifestyle and behavioral interventions, expansion of herbal and natural menopause treatments, increasing awareness of menopause symptom managemen.

The growing demand for hormone replacement therapies (HRT) is expected to drive the growth of the menopausal disorder treatment market in the coming years. Hormone replacement therapy involves supplementing or replacing hormones to relieve symptoms associated with menopause or hormonal imbalances. This demand is fueled by increased awareness and the need for effective management of menopausal symptoms. HRT addresses menopausal disorders by replenishing estrogen and progesterone levels, restoring hormonal balance, and alleviating disruptive symptoms such as hot flashes, night sweats, and mood swings, thereby improving quality of life. For example, in October 2024, the NHS Business Services Authority (NHSBSA), a UK-based support services organization, reported that HRT prescriptions increased by 22% to 13 million, while the number of identified patients rose by 12%, from 2.3 million in 2022/23 to 2.6 million in 2023/24. Consequently, the rising demand for hormone replacement therapies is fueling the growth of the menopausal disorder treatment market.

Major companies in the menopausal disorder treatment market are developing innovative nonhormonal neurokinin 3 (NK3) receptor antagonist therapies to manage vasomotor symptoms effectively without using hormone therapy. These novel therapies work by blocking NK3 receptors to alleviate menopausal symptoms without hormones. For example, in December 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, received European Commission approval for Veozah (fezolinetant), a nonhormonal NK3 receptor antagonist for treating moderate to severe vasomotor symptoms (VMS), including hot flashes and night sweats in menopausal women. Veozah targets neurons in the brain's temperature regulation center to reduce the frequency and intensity of these symptoms.

In February 2025, Cosette Pharmaceuticals, a US-based specialty pharmaceutical company focused on women's health and dermatology, acquired Mayne Pharma Pty Ltd. (Australia) for US$430 million. The acquisition strengthens Cosette Pharmaceuticals' position in the women's health market by adding patented, high-growth menopause therapies and expanding its portfolio of dermatology and specialty products. Mayne Pharma Pty Ltd. is an Australia-based company that provides women's health products, including menopause medications such as Bijuva, Intrarosa, and Imvexxy, along with other specialty and dermatology drugs.

Major companies operating in the menopausal disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Sanofi SA, AstraZeneca plc, Eli Lilly and Company, Novo Nordisk A/S, Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Ipsen SA, Dr. Reddy's Laboratories Ltd., Theramex, Besins Healthcare, Mithra Pharmaceuticals, Duchesnay USA, Fervent Pharmaceuticals, Joylux Inc., TherapeuticsMD Inc.

North America was the largest region in the menopausal disorder treatment market in 2025. The regions covered in the menopausal disorder treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the menopausal disorder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The menopausal disorder treatment market includes revenues earned by entities providing services such as estrogen-only therapy, combined estrogen and progesterone therapy, bone health management, and hormone level testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The menopausal disorder treatment market also includes sales of hormone replacement therapy (HRT) medications, non-hormonal therapies, dietary supplements, and vaginal estrogen products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Menopausal Disorder Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses menopausal disorder treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for menopausal disorder treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The menopausal disorder treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Treatment Type: Hormone Replacement Therapy; Non-Hormonal Treatment; Herbal Supplements; Lifestyle Modifications
• 2) By Stages: Menopause; Postmenopause; Perimenopause
• 3) By Application: Hot Flashes; Night Sweats; Mood Swings; Vaginal Dryness
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
• 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
• Subsegments:
• 1) By Hormone Replacement Therapy (HRT): Estrogen Therapy; Progesterone Therapy; Combination Therapy; Transdermal Patches; Vaginal Estrogen; Oral Tablets
• 2) By Non-Hormonal Treatment: Selective Estrogen Receptor Modulators (SERMs); Antidepressants; Gabapentin; Clonidine; Bisphosphonates; Calcium And Vitamin D Supplements
• 3) By Herbal Supplements: Black Cohosh; Red Clover; Dong Quai; Ginseng; Soy Isoflavones; Flaxseed
• 4) By Lifestyle Modifications: Dietary Changes; Regular Physical Exercise; Stress Management Techniques; Cognitive Behavioral Therapy (CBT); Smoking Cessation; Sleep Hygiene Practices
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd; Merck & Co Inc.; Novartis AG; Bayer AG; Bristol-Myers Squibb Company; Sanofi SA; AstraZeneca plc; Eli Lilly and Company; Novo Nordisk A/S; Abbott Laboratories; GlaxoSmithKline plc; Teva Pharmaceutical Industries Ltd.; Ipsen SA; Dr. Reddy's Laboratories Ltd.; Theramex; Besins Healthcare; Mithra Pharmaceuticals; Duchesnay USA; Fervent Pharmaceuticals; Joylux Inc.; TherapeuticsMD Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Menopausal Disorder Treatment Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Menopausal Disorder Treatment Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Menopausal Disorder Treatment Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Menopausal Disorder Treatment Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Sustainability, Climate Tech & Circular Economy
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Rising Preference For Non-Hormonal Menopause Therapies
  • 4.2.2 Increasing Adoption Of Personalized Hormone Replacement Therapy
  • 4.2.3 Growing Use Of Lifestyle And Behavioral Interventions
  • 4.2.4 Expansion Of Herbal And Natural Menopause Treatments
  • 4.2.5 Increasing Awareness Of Menopause Symptom Management

5. Menopausal Disorder Treatment Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Specialty Gynecology Clinics
• 5.3 Women'S Health Clinics
• 5.4 Homecare Settings
• 5.5 Wellness Centers

6. Menopausal Disorder Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Menopausal Disorder Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Menopausal Disorder Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Menopausal Disorder Treatment Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Menopausal Disorder Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Menopausal Disorder Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Menopausal Disorder Treatment Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Menopausal Disorder Treatment Market Segmentation

• 9.1. Global Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hormone Replacement Therapy, Non-Hormonal Treatment, Herbal Supplements, Lifestyle Modifications
• 9.2. Global Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Menopause, Postmenopause, Perimenopause
• 9.3. Global Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hot Flashes, Night Sweats, Mood Swings, Vaginal Dryness
• 9.4. Global Menopausal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
• 9.5. Global Menopausal Disorder Treatment Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Specialty Clinics, Homecare, Other End-Users
• 9.6. Global Menopausal Disorder Treatment Market, Sub-Segmentation Of Hormone Replacement Therapy (HRT), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Estrogen Therapy, Progesterone Therapy, Combination Therapy, Transdermal Patches, Vaginal Estrogen, Oral Tablets
• 9.7. Global Menopausal Disorder Treatment Market, Sub-Segmentation Of Non-Hormonal Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Selective Estrogen Receptor Modulators (SERMs), Antidepressants, Gabapentin, Clonidine, Bisphosphonates, Calcium And Vitamin D Supplements
• 9.8. Global Menopausal Disorder Treatment Market, Sub-Segmentation Of Herbal Supplements, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Black Cohosh, Red Clover, Dong Quai, Ginseng, Soy Isoflavones, Flaxseed
• 9.9. Global Menopausal Disorder Treatment Market, Sub-Segmentation Of Lifestyle Modifications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Dietary Changes, Regular Physical Exercise, Stress Management Techniques, Cognitive Behavioral Therapy (CBT), Smoking Cessation, Sleep Hygiene Practices

10. Menopausal Disorder Treatment Market Regional And Country Analysis

• 10.1. Global Menopausal Disorder Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Menopausal Disorder Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Menopausal Disorder Treatment Market

• 11.1. Asia-Pacific Menopausal Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Menopausal Disorder Treatment Market

• 12.1. China Menopausal Disorder Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Menopausal Disorder Treatment Market

• 13.1. India Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Menopausal Disorder Treatment Market

• 14.1. Japan Menopausal Disorder Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Menopausal Disorder Treatment Market

• 15.1. Australia Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Menopausal Disorder Treatment Market

• 16.1. Indonesia Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Menopausal Disorder Treatment Market

• 17.1. South Korea Menopausal Disorder Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Menopausal Disorder Treatment Market

• 18.1. Taiwan Menopausal Disorder Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Menopausal Disorder Treatment Market

• 19.1. South East Asia Menopausal Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Menopausal Disorder Treatment Market

• 20.1. Western Europe Menopausal Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Menopausal Disorder Treatment Market

• 21.1. UK Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Menopausal Disorder Treatment Market

• 22.1. Germany Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Menopausal Disorder Treatment Market

• 23.1. France Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Menopausal Disorder Treatment Market

• 24.1. Italy Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Menopausal Disorder Treatment Market

• 25.1. Spain Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Menopausal Disorder Treatment Market

• 26.1. Eastern Europe Menopausal Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Menopausal Disorder Treatment Market

• 27.1. Russia Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Menopausal Disorder Treatment Market

• 28.1. North America Menopausal Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Menopausal Disorder Treatment Market

• 29.1. USA Menopausal Disorder Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Menopausal Disorder Treatment Market

• 30.1. Canada Menopausal Disorder Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Menopausal Disorder Treatment Market

• 31.1. South America Menopausal Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Menopausal Disorder Treatment Market

• 32.1. Brazil Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Menopausal Disorder Treatment Market

• 33.1. Middle East Menopausal Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Menopausal Disorder Treatment Market

• 34.1. Africa Menopausal Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Segmentation By Stages, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Menopausal Disorder Treatment Market Regulatory and Investment Landscape

36. Menopausal Disorder Treatment Market Competitive Landscape And Company Profiles

• 36.1. Menopausal Disorder Treatment Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Menopausal Disorder Treatment Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Menopausal Disorder Treatment Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

37. Menopausal Disorder Treatment Market Other Major And Innovative Companies

• Bristol-Myers Squibb Company, Sanofi SA, AstraZeneca plc, Eli Lilly and Company, Novo Nordisk A/S, Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Ipsen SA, Dr. Reddy's Laboratories Ltd., Theramex, Besins Healthcare, Mithra Pharmaceuticals, Duchesnay USA, Fervent Pharmaceuticals

38. Global Menopausal Disorder Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Menopausal Disorder Treatment Market

40. Menopausal Disorder Treatment Market High Potential Countries, Segments and Strategies

• 40.1 Menopausal Disorder Treatment Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Menopausal Disorder Treatment Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Menopausal Disorder Treatment Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer